SCHEMBL2617044

SCHEMBL2617044

CC(=O)C1CCC(C(C)=O)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.38
LMNA P02545 3/20 0.36
NAMPT P43490 1/20 0.36
ALDH1A1 P00352 2/20 0.35
TSHR P16473 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
CES2 O00748 1/20 0.35
CES1 P23141 1/20 0.35
HPGD P15428 1/20 0.33
THPO P40225 1/20 0.33
FFAR3 O14843 1/20 0.33
LCK P06239 1/20 0.33
FYN P06241 1/20 0.33
EPHX2 P34913 1/20 0.33
PLG P00747 1/20 0.32
PLAT P00750 1/20 0.32
CA1 P00915 1/20 0.31
ALOX15 P16050 1/20 0.31
BLM P54132 1/20 0.31
PMP22 Q01453 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL76462 1.00
SCHEMBL13165462 1.00 MAPT (0.38) MAPTLMNANAMPTALDH1A1TSHR
SCHEMBL13165512 1.00 MAPT (0.38) MAPTLMNANAMPTALDH1A1TSHR
Ammonia Solution, Strong SCHEMBL29124228 0.96
SCHEMBL27641897 0.96
Hydrochloric Acid SCHEMBL27993671 0.96
SCHEMBL31461753 0.96
Acetic Acid SCHEMBL1557976 0.93 FFAR3 (0.47) MAPTLMNANAMPTALDH1A1TSHR
SCHEMBL10678884 0.90 MAPT (0.33) MAPTNAMPTALDH1A1TSHRTDP1
SCHEMBL14336925 0.90 MAPT (0.33) MAPTNAMPTALDH1A1TSHRTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 219 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250197374-A1 WEE1 DEGRADING COMPOUNDS AND USES THEREOF BRISTOL-MYERS SQUIBB COMPANY 2025-06-19 US disclosed
WO-2024042834-A1 MIXED COMPOSITION, RETARDATION FILM, CIRCULARLY POLARIZING PLATE, PRODUCTION METHOD FOR MIXED COMPOSITION 住友化学株式会社 2024-02-29 WO disclosed
US-20240018312-A1 METHOD FOR ENHANCING ADHESION STRENGTH OF RESIN MOLDED ARTICLE TO AN ADHESIVE, AND COMPOSITE ENHANCED IN ADHESION STRENGTH ENEOS CORPORATION (JP) 2024-01-18 US disclosed
US-11874434-B2 Ophthalmic devices comprising photochromic materials with reactive substituents JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-01-16 US disclosed
US-11874434-B2 Ophthalmic devices comprising photochromic materials with reactive substituents JOHNSON & JOHNSON VISION CARE, INC. (US) 2024-01-16 US disclosed
US-20230399773-A1 CORE-SHEATH COMPOSITE FIBER, PRODUCTION METHOD THEREFOR, AND FIBER STRUCTURE KURARAY CO., LTD. (JP) 2023-12-14 US disclosed
US-20230399460-A1 Liquid Crystalline Polyesters (LCP) and Thermoplastic Compositions having Low Dielectric Constant (Dk) and Dissipation Factor (Df) SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-12-14 US disclosed
US-20230332334-A1 LIQUID CRYSTAL POLYESTER FIBERS AND METHOD FOR PRODUCING SAME KURARAY CO., LTD. (JP) 2023-10-19 US disclosed
US-20230332350-A1 DOUBLE BRAID ROPE STRUCTURE KURARAY CO., LTD. (JP) 2023-10-19 US disclosed
US-20230323596-A1 ROPES WITH ENHANCED CBOS FATIGUE LIFE KURARAY CO., LTD. (JP) 2023-10-12 US disclosed
US-20070278460-A1 Photochromic materials comprising metallocenyl groups TRANSITIONS OPTICAL LIMITED (IE) 2007-12-06 US disclosed
WO-2007140058-A1 PHOTOCHROMIC MATERIALS COMPRISING METALLOCENYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2007-12-06 WO disclosed
US-20070278461-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2007-12-06 US disclosed
US-20070278461-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TRANSITIONS OPTICAL, INC. (US) 2007-12-06 US disclosed
US-7303695-B2 Process for producing optically active liquid crystalline polymer compound NIPPON OIL CORPORATION (JP) 2007-12-04 US disclosed
US-7303695-B2 Process for producing optically active liquid crystalline polymer compound NIPPON OIL CORPORATION (JP) 2007-12-04 US disclosed
WO-2007071396-A2 PYRAZINOYLGUANIDINE COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY OR ALLERGIC CONDITIONS NOVARTIS AG (CH) 2007-06-28 WO disclosed
US-7189299-B2 Thermal-dye-transfer label capable of reproducing flesh tones EASTMAN KODAK COMPANY (US) 2007-03-13 US disclosed
WO-2007005289-A1 MONOMERS AND POLYMERS COMPRISING CONJUGATED GROUPS AND METHODS FOR MAKING THEREOF GENERAL ELECTRIC COMPANY (US) 2007-01-11 WO disclosed
WO-2007005594-A2 PROCESS FOR THE REDUCTIVE AMINATION OF ALDEHYDES AND KETONES VIA THE FORMATION OF MACROCYCLIC POLYIMINE INTERMEDIATES DOW GLOBAL TECHNOLOGIES, INC. (US) 2007-01-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070278461-A1 PHOTOCHROMIC MATERIALS COMPRISING HALOALKYL GROUPS TELO2, EYA3, CRY2 MAPT 1954/4885LMNA 1784/4885NAMPT 1268/4885
US-20250197374-A1 WEE1 DEGRADING COMPOUNDS AND USES THEREOF WEE1, WEE2, PPME1 MAPT 2871/4885LMNA 2661/4885NAMPT 2735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.